Search

Your search keyword '"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma economics"' showing total 2 results

Search Constraints

Start Over You searched for: Descriptor "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma economics" Remove constraint Descriptor: "Precursor B-Cell Lymphoblastic Leukemia-Lymphoma economics" Topic inotuzumab ozogamicin Remove constraint Topic: inotuzumab ozogamicin
2 results on '"Precursor B-Cell Lymphoblastic Leukemia-Lymphoma economics"'

Search Results

1. Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States.

2. The Clinical and Cost Effectiveness of Inotuzumab Ozogamicin for the Treatment of Adult Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.

Catalog

Books, media, physical & digital resources